Immunome IMNM

$ 12.81 10.53%

Quarterly report 2024-Q2
added 08-12-2024

Immunome Balance Sheet 2011-2024 | IMNM

Annual Balance Sheet Immunome

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-39.2 M	-2.22 M	-1.05 M	-	-	-	-	-	-	-
Long Term Debt	-	-	-	134 K	113 K	325 K	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	366 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	142 K	39 M	28.1 M	-	-	-	-	-	-	-
Total Current Liabilities	21.8 M	7.33 M	9.73 M	3.04 M	-	-	-	-	-	-	-	-	-
Total Liabilities	28.7 M	7.39 M	9.74 M	3.18 M	40.7 M	29.7 M	-	-	-	-	-	-	-
Deferred Revenue	10.5 M	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-223 M	-116 M	-79.1 M	-54.4 M	-36.6 M	-26.1 M	-	-	-	-	-	-	-
Total Assets	149 M	24 M	57.9 M	44.5 M	5.06 M	4.45 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	98.7 M	20.3 M	49.2 M	39.8 M	2.64 M	-	-	-	-	-	-	-	-
Book Value	120 M	16.7 M	48.2 M	41.3 M	-35.6 M	-25.2 M	-	-	-	-	-	-	-
Total Shareholders Equity	120 M	16.7 M	48.2 M	41.3 M	-35.6 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Immunome

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	2.48 M	1.21 M	1.34 M	-	-	-	-	-	-	-	-	-	-	134 K	134 K	134 K	134 K	134 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	42.4 M	34.2 M	28.7 M	87.1 M	32.1 M	34.3 M	7.39 M	7.46 M	-	9.85 M	9.74 M	7.76 M	3.52 M	4.71 M	3.18 M	3.18 M	3.18 M	3.18 M	1.8 M	1.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	12.6 M	12.7 M	10.5 M	17 M	17.7 M	18.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-388 M	-352 M	-223 M	-130 M	-126 M	-120 M	-116 M	-108 M	-	-90.8 M	-79.1 M	-71.3 M	-63.5 M	-58.3 M	-54.4 M	-54.4 M	-54.4 M	-54.4 M	-36.6 M	-36.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	296 M	320 M	149 M	93.2 M	41.4 M	48.1 M	24 M	30.5 M	-	47.7 M	57.9 M	62.6 M	64.1 M	42.6 M	44.5 M	44.5 M	44.5 M	44.5 M	5.06 M	5.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	165 M	270 M	98.7 M	90.6 M	38.4 M	44.4 M	20.3 M	27.1 M	34.6 M	42.9 M	49.2 M	56.2 M	59.8 M	36.3 M	39.8 M	39.8 M	39.8 M	39.8 M	2.54 M	2.54 M	-	-	1.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	254 M	286 M	120 M	6.08 M	9.34 M	13.9 M	16.7 M	23.1 M	-	37.9 M	48.2 M	54.8 M	60.6 M	37.9 M	41.3 M	41.3 M	41.3 M	41.3 M	3.26 M	3.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	254 M	286 M	120 M	6.08 M	9.34 M	13.9 M	16.7 M	23.1 M	30.3 M	37.9 M	48.2 M	54.8 M	60.6 M	37.9 M	41.3 M	41.3 M	41.3 M	41.3 M	-35.6 M	-35.6 M	-30 M	-	-25.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency